Mary Ann Liebert Inc. was founded in 1980 by Mary Ann Liebert in New Rochelle, NY. The company publishes peer-reviewed journals, books and trade magazines in a variety of fields. A sample of journals, include Genetic Engineering & Biotechnology News, Human Gene Therapy and Women's Health. BioConferences International Inc. is a subsidiary of Mary Ann Liebert Inc. This company's focus is to organize symposiums and conferences in Biotechnology, Women's Health, Alternative Medicine, Law and more.
Some content from Wikipedia, licensed under CC BY-SA
Subscribe to rss feed
A new study published in Population Health Management, which builds on previous work in the journal, describes the Academic Payvider model, a joint approach to care and coverage aimed at reforming the relationship between ...
May 7, 2024
0
0
A new study presents data reflecting the current state of female representation within the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS). The study is published in Facial Plastic Surgery & Aesthetic ...
May 3, 2024
0
0
A new study examines the development of two machine learning models to classify the immunophenotype of a cancer specimen.
Apr 16, 2024
0
0
Two new review articles in AI in Precision Oncology explore the role of artificial intelligence (AI) in early cancer detection. A primer provides an overview of AI, and the second review examines the promising clinical applications ...
Apr 11, 2024
0
1
A new study published in the journal Diabetes Technology & Therapeutics has evaluated the use of tirzepatide in overweight/obese adults with type 1 diabetes. Tirzepatide is approved for managing type 2 diabetes. It improves ...
Mar 25, 2024
0
1
Retear and failure to heal are significant post-operative complications in rotator cuff repair surgery despite the use of commercially available rotator cuff repair grafts. Advances in tissue engineering have demonstrated ...
Mar 18, 2024
0
0
Recent clinical trials utilizing high doses of adeno-associated virus (AAV) vectors have highlighted a new challenge to AAV gene transfer—activation of the complement system. A new article in Human Gene Therapy describes ...
Feb 22, 2024
0
4
A new study evaluates an artificial intelligence (AI)-based algorithm for autocontouring prior to radiotherapy in head and neck cancer. Manual contouring to pinpoint the area of treatment requires significant time, and an ...
Feb 8, 2024
0
7
A new study in the Journal of Neurotrauma has shown that Angiotensin II type 2 receptor (AT2R) activation improves neurological and cardiac deficiencies caused by traumatic brain injury (TBI) in mice. AT2R activation is known ...
Feb 6, 2024
0
0
A new study suggests that high-intensity training (HIT), compared to conventional training, may improve walking ability in patients with chronic traumatic brain injury (TBI). Possible secondary benefits may include improved ...
Feb 1, 2024
0
6
